SPIA
VIVO

Steward Partners Investment Advisory’s Meridian Bioscience Inc VIVO Stock Holding History

Steward Partners Investment Advisory’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,400
Closed -$36.8K – 7515
2021
Q1 		$36.8K Buy
+1,400
New +$33.3K ﹤0.01% 2152
2018
Q4 		– Sell
-200
Closed -$3K – 2346
2018
Q3 		$3K Hold
200
– – ﹤0.01% 2315
2018
Q2 		$3K Hold
200
– – ﹤0.01% 2168
2018
Q1 		$2K Buy
+200
New +$2.96K ﹤0.01% 2065

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Steward Partners Investment Advisory's VIVO Position: Q2 2021 in Review

Steward Partners Investment Advisory sold out of Meridian Bioscience Inc (VIVO) in Q2 2021, closing a stake of 1,400 shares — an estimated $36.8K sold.

Steward Partners Investment Advisory first reported a position in VIVO in Q1 2018 and held it in 4 quarters. The position peaked at $36.8K in Q1 2021. 189 funds tracked by Wall St. Rank hold VIVO as of Q2 2021.

  • Steward Partners Investment Advisory reported no remaining Meridian Bioscience Inc position as of Q2 2021 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 1,400 Meridian Bioscience Inc shares in Q2 2021, an estimated $36.8K.
  • Steward Partners Investment Advisory first reported a position in Meridian Bioscience Inc in Q1 2018 and held it in 4 quarters.
  • Steward Partners Investment Advisory's Meridian Bioscience Inc position peaked at $36.8K in Q1 2021.
  • 189 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2021, filed 13 Aug 2021.